Timberlyne Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$180M

Timberlyne Therapeutics is a biopharmaceutical company developing novel therapies for autoimmune disorders, focusing on advancing a monoclonal antibody targeting CD38.